Your browser doesn't support javascript.
loading
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy.
Sleightholm, Richard L; Neilsen, Beth K; Li, Jing; Steele, Maria M; Singh, Rakesh K; Hollingsworth, Michael A; Oupicky, David.
Afiliação
  • Sleightholm RL; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 985830 Nebraska Medical Center, Omaha, NE, USA.
  • Neilsen BK; Eppley Institute, University of Nebraska Medical Center, 985950 Nebraska Medical Center, Omaha, NE, USA.
  • Li J; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 985830 Nebraska Medical Center, Omaha, NE, USA.
  • Steele MM; Eppley Institute, University of Nebraska Medical Center, 985950 Nebraska Medical Center, Omaha, NE, USA.
  • Singh RK; Department of Pathology and Microbiology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, NE, USA.
  • Hollingsworth MA; Eppley Institute, University of Nebraska Medical Center, 985950 Nebraska Medical Center, Omaha, NE, USA; Department of Pathology and Microbiology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, NE, USA; Department of Biochemistry and Molecular Biology, University of Ne
  • Oupicky D; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, 985830 Nebraska Medical Center, Omaha, NE, USA. Electronic address: david.oupicky@unmc.edu.
Pharmacol Ther ; 179: 158-170, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28549596
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Receptores CXCR4 / Quimiocina CXCL12 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Receptores CXCR4 / Quimiocina CXCL12 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos